Rebecca Rabenstein is an associate in the Washington, D.C. office of Latham & Watkins and a member of the Intellectual Property Litigation Practice.
Dr. Rabenstein’s practice focuses on patent litigation, particularly for clients in the pharmaceutical, biotechnology, and life sciences industries. She has experience in all stages of patent litigation, including pre-suit investigation, fact and expert discovery, claim construction, pre-trial, trial, and appeal.
Prior to joining Latham, Dr. Rabenstein served as a law clerk to Judge Kimberly A. Moore of the United States Court of Appeals for the Federal Circuit. She earned her JD from the University of Michigan Law School, where she received Latin honors and served as executive note editor of the Michigan Telecommunications and Technology Law Review.
Dr. Rabenstein earned her PhD in Neuroscience based on her research into the role of a cytoskeleton-regulating protein in synaptic plasticity underlying learning and memory formation. She also studied the use of small molecule nicotinic acetylcholine receptor antagonists as novel antidepressants. For her undergraduate thesis research, Dr. Rabenstein studied the distributed neuronal network involved in the performance of an appetitive task. Dr. Rabenstein’s research incorporated a broad variety of techniques, including those used in cellular and molecular biology, physiology, pharmacology, and behavioral analysis. As a result of her graduate and undergraduate research and various collaborative efforts, Dr. Rabenstein has co-authored several scientific articles.